Comparison of skeletal complications and treatment patterns associated with early vs. delayed zoledronic acid therapy in multiple myeloma

Our  privacy policy and terms of use on our website have changed. Additionally, this website uses cookies to analyze traffic and help us improve the user experience of the site. Please review our privacy policy and terms regarding cookies for additional information. By continuing to use this site you agree to the privacy policy and terms of use, including the use of cookies.